WhatsApp

Insulin Resistance Treatment in the UAE

Picture of Dr. Hecham Harb

Dr. Hecham Harb

Consultant Endocrinologist & Medical Director

Insulin resistance treatment in the UAE

Book Your Consultation

  • Specialist consultation
  • Personalized Coaching
  • Body Composition Analysis
Book your consultation
Quick answer

Insulin resistance means your muscle, liver and fat cells respond poorly to insulin, so the pancreas produces more of it to hold blood sugar steady. It often develops years before prediabetes and rarely causes symptoms. Endocare's endocrinologists in the UAE assess it through a blood panel that includes fasting insulin and HOMA-IR, alongside your history and a body composition analysis.

Key takeaways
  • Insulin resistance is a reduced response of muscle, liver and fat cells to insulin. The pancreas compensates by producing more, and blood sugar can remain normal for years while it does.
  • It rarely causes symptoms, but several signs are associated with it, including darkened skin at the neck folds, skin tags, weight carried around the middle and irregular periods.
  • Your endocrinologist assesses it from HbA1c, fasting glucose and fasting insulin, from which HOMA-IR is calculated, together with your history and body composition. No single test makes the diagnosis alone.
  • There is no single HOMA-IR cut-off. Published thresholds run from 1.6 to above 3, so your own laboratory's reference range and your endocrinologist's reading of the whole panel govern.
  • Treatment starts with eating pattern, activity, sleep and weight. Where medication has a role, metformin and the GLP-1 class are the ones your endocrinologist is most likely to discuss.
  • Untreated insulin resistance can progress to prediabetes and type 2 diabetes, which is why it is worth assessing before any diagnosis exists.
In one line: Insulin resistance often sits underneath rising blood sugar for years, and Endocare assesses and treats the mechanism rather than waiting for a diagnosis.

01  Introduction

Insulin resistance underlies most cases of prediabetes and type 2 diabetes, and it can develop years before either diagnosis. This page explains what insulin resistance is, the signs associated with it, how our endocrinologists in Dubai and Abu Dhabi assess it, what a HOMA-IR result does and does not tell you, and how treatment works.

Insulin resistance is a reduced response of the body's cells, mainly in muscle, liver and fat tissue, to the hormone insulin. Glucose enters the cells less easily, and the pancreas compensates by producing more insulin to keep blood sugar in range. The US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes the consequence: blood sugar can remain normal for years while the compensation holds, rises into the prediabetes range as it begins to fail, and can progress to type 2 diabetes.

That sequence is the reason assessment matters early. By the time an HbA1c turns abnormal, the mechanism has often been at work for years.

Insulin resistance itself produces no reliable symptoms. As long as the pancreas compensates, blood sugar stays normal and nothing feels wrong, which is why no symptom list can rule it in or out. Several signs are associated with it, and any of them is a reason to ask for the panel rather than a diagnosis in itself.

  • Acanthosis nigricans, darkened velvety patches of skin in the neck folds, armpits or groin
  • Skin tags, most often on the neck or in the armpits
  • Weight carried around the middle, which can be present at a body mass index that looks normal
  • Tiredness in the hour or two after a large meal
  • Frequent hunger or cravings for sugar between meals
  • Irregular or absent periods, which often points towards polycystic ovary syndrome (PCOS)
  • Raised triglycerides, a low HDL cholesterol or fatty liver on an existing report
 

None of these confirms insulin resistance, and their absence does not exclude it, which is why our endocrinologists assess it on a panel rather than on how you feel.

Cleveland Clinic notes that excess fat in the belly and around the organs, called visceral fat, especially raises the risk. Inactivity, poor sleep and genetics contribute. In women, insulin resistance is common in PCOS: the two conditions frequently occur together and each can worsen the other, although neither is the sole cause of the other. Insulin resistance also commonly occurs alongside raised triglycerides, higher blood pressure and fatty liver, a cluster doctors call metabolic syndrome.

The International Diabetes Federation (IDF) puts adult diabetes prevalence in the UAE at 20.7%, about 1,274,200 adults, nearly double the global rate of roughly one adult in nine, which is the scale our diabetes treatment in the UAE page is built around. Insulin resistance is the mechanism underneath most of that, which means the population carrying it is larger again than the population already diagnosed.

A cross-sectional study of UAE residents published in Scientific Reports found that 40% of Emirati nationals and 40% of Asian non-Arab residents fell into either the prediabetes or the diabetes range. South Asian and Arab ancestry both carry metabolic risk at a lower body weight than European ancestry does, which is one reason our endocrinologists read your weight alongside a body composition analysis rather than on its own.

Most residents who find out early find out through a screening: a workplace or wellness check, a community screening under the Ministry of Health and Prevention (MoHAP) campaign, which completed more than 150,000 screenings in its first year, or the preventive screening benefit inside a mandatory insurance plan. Our endocrinologists work within the Emirates Diabetes and Endocrine Society consensus for managing type 2 diabetes, updated in 2026, alongside the international guidance this page cites.

The three sit on one spectrum and are often confused with each other. They are not the same thing, and the difference decides what gets tested and what gets treated.

Insulin resistancePrediabetesType 2 diabetes
What it isThe mechanism. Cells respond poorly to insulinA stage. Blood sugar above normal, below the diabetes thresholdA diagnosis. Blood sugar at or above the diabetes threshold
Typical HbA1cOften normal5.7% to 6.4%6.5% or above
How it is foundFasting insulin and HOMA-IR, read with the wider panel and body compositionHbA1c, fasting glucose or an oral glucose tolerance testThe same tests, at higher values
What treatment aims atRestoring insulin sensitivityReturning blood sugar to the normal rangeReaching an HbA1c target and protecting the eyes, kidneys, nerves and heart

The blood panel

Assessment starts with a blood panel. HbA1c, fasting glucose and, where needed, an oral glucose tolerance test show whether blood sugar has begun to rise. Fasting insulin is a standard part of the panel at Endocare, run alongside the other markers, and from fasting insulin and fasting glucose your endocrinologist calculates HOMA-IR, an index of insulin resistance. MedlinePlus, the health information service of the US National Library of Medicine, lists diagnosing insulin resistance among the uses of the insulin blood test.

No single result makes the diagnosis on its own. Your endocrinologist reads the panel as a whole, together with your history, your other conditions and your body composition, and our blood test panels cover the markers involved.

The body composition scan

Because visceral fat is a major driver and a weighing scale cannot show how much of it you carry, body composition is part of the assessment rather than an extra. The multi-frequency bio-impedance scan reports body fat percentage, visceral fat rating, skeletal muscle mass and body water, and this body composition analysis is included free of charge with every consultation.

HOMA-IR stands for the homeostatic model assessment of insulin resistance. Your endocrinologist calculates it from your fasting insulin and your fasting glucose taken at the same moment. A higher number means the pancreas is producing more insulin to hold the same blood sugar, which is what insulin resistance looks like on a blood test before glucose itself moves.

There is no single threshold above which the result is abnormal, and this page will not publish one. Studies define their own cut-off in the population they studied, and the figures disagree by a wide margin. Laboratories also run different insulin assays, so the same sample can produce different numbers in different labs. A 2025 study of a Qatari cohort set out the published cut-offs alongside its own, and the spread is the point:

Population studiedPublished HOMA-IR threshold
Oman1.6
Qatar, biobank cohort1.878
Hungary2.32
Turkey2.46
Brazil2.7
Korea3.04
 

What this means in practice: read your result against the reference range printed on your own laboratory report rather than against a number from an article, and treat it as one input among several. Your endocrinologist reads it alongside your HbA1c, your fasting glucose, your lipids, your history and your body composition. A single HOMA-IR figure in isolation is not a diagnosis, and a result inside a reference range does not exclude insulin resistance where the rest of the picture points to it.

Eating pattern

Treatment acts on the causes, and the eating pattern is the first lever. Our clinical nutritionist works towards a Mediterranean-style pattern: vegetables, legumes, whole grains, fish, nuts and olive oil, with refined carbohydrates and sugar-sweetened drinks reduced rather than banned. Two changes carry most of the effect. Raising fiber slows how quickly glucose arrives in the blood, and pairing carbohydrates with protein or fat flattens the rise after a meal. The plan is built from your scan and your habits, with practical swaps rather than a generic meal plan.

Ramadan is worth planning for rather than improvising through. A long fast followed by a large iftar produces sharp glucose swings, and Ramadan eating patterns often add weight. Keeping the suhoor meal, weighting it towards protein and slow carbohydrates, breaking the fast modestly before the main meal and keeping fluids up across the evening are the adjustments our endocrinologists suggest most often.

Movement

Physical activity improves insulin sensitivity through a route that does not depend on weight loss, because working muscle takes up glucose without needing insulin to do it. The US Physical Activity Guidelines set the target at 150 to 300 minutes a week of moderate-intensity aerobic activity, plus muscle-strengthening work on at least two days. The resistance half matters here more than most people expect: skeletal muscle is where most glucose is disposed of, so building it enlarges the tissue doing the work. Your body composition scan tracks that muscle directly, which is what makes the progress visible.

Weight

Losing weight improves insulin sensitivity, and the scale of change that matters is well evidenced. NIDDK reports that in the Diabetes Prevention Program, participants worked towards a 7% weight loss, and structured lifestyle change was associated with a 58% lower risk of progressing to type 2 diabetes. Endocare's lifestyle coaches build that work around your scan, and your endocrinologist reviews you monthly, repeating the body composition analysis and adjusting the plan as your markers move.

Medication

Where medication has a role, two options come up most often. Metformin improves the liver's response to insulin and reduces the glucose it releases, and NIDDK reports that it reduced progression to type 2 diabetes by 31% in the Diabetes Prevention Program. GLP-1 receptor agonists act on appetite and on blood sugar together, and the weight loss they support improves insulin sensitivity in turn, which is why they appear in this conversation as often as they do.

Neither is automatic. Insulin resistance on its own is not a licensed indication for either, so your endocrinologist prescribes on the whole picture: your results, your weight, your other conditions and what the lifestyle layer has already achieved. Patients should not decide by themselves to start a GLP-1 medicine. A doctor review is critical to ensure the treatment is safe and appropriate for the individual.

Where it helps, your endocrinologist may also suggest a continuous glucose monitor (CGM), a small sensor that records blood sugar continuously and shows how meals, activity and sleep move it, which helps target the changes that matter most in your case.

For many women, insulin resistance and PCOS occur together, and treating one can help the other. The relationship runs through hormonal imbalance and weight, and Endocare's endocrinologists treat the two as one picture rather than referring them apart.

Where weight is the primary concern, many patients ask whether weight loss injections can help insulin resistance. For suitable patients they can, and that question has its own page.

There is no reliable symptom, because blood sugar stays normal while the pancreas compensates. Signs associated with it include darkened velvety skin at the neck folds or armpits, skin tags, weight carried around the middle, tiredness after large meals, sugar cravings and irregular periods. None of them confirms it, which is why assessment runs on a blood panel.

No single test answers it alone. Your endocrinologist assesses a blood panel that includes HbA1c, fasting glucose and fasting insulin, together with your history, your body composition and the conditions associated with it.

There is no single normal. Published thresholds range from 1.6 in an Omani population to 3.04 in a Korean one, and laboratories run different insulin assays, so the reference range printed on your own report is the one that applies. Your endocrinologist reads the figure alongside the rest of the panel rather than on its own.

Not directly. HbA1c shows whether blood sugar has started to rise, which is the consequence of insulin resistance rather than the mechanism itself. A normal HbA1c does not exclude it, which is why the panel also includes fasting insulin.

Yes, these tests provide meaningful information. Fasting insulin is a standard part of the assessment panel at Endocare, and HOMA-IR, calculated from fasting insulin and fasting glucose, gives your endocrinologist an index of insulin resistance. Neither is sufficient on its own to make the diagnosis.

Metformin and the GLP-1 receptor agonist class are the two your endocrinologist is most likely to discuss. Neither is automatic, and insulin resistance on its own is not a licensed indication for either, so the decision rests on your whole picture rather than on one result.

Lifestyle changes may help prevent or reverse insulin resistance, particularly through weight loss, better sleep and regular activity. The improvement lasts for as long as those changes are sustained.

No. Insulin resistance is the mechanism, and prediabetes is the stage at which blood sugar has risen above normal. Insulin resistance often comes first, sometimes by years.

The International Diabetes Federation puts adult diabetes prevalence in the UAE at 20.7%, nearly double the global rate, and insulin resistance is the mechanism underneath most of it. A UAE study found 40% of Emirati nationals and 40% of Asian non-Arab residents in either the prediabetes or the diabetes range.

An endocrinologist, a diabetologist or a general practitioner specialized in metabolic health. Insulin resistance sits across weight, hormones and blood sugar, which is specialist territory.

Book a consultation at Endocare

If your results, your family history or your own reading has raised the question of insulin resistance, book an assessment. Your endocrinologist will review the whole picture with you, including any results you have already collected, and treat what is found. Endocare sees patients at Building 27, Block B, Unit 504 B, Dubai Healthcare City, Dubai (+971 4 285 3885) and at Al Bateen, Tower C2, Unit 104, Abu Dhabi (+971 2 582 6178). You can also send us a message on WhatsApp.

Book Your Consultation

  • Specialist consultation
  • Personalized Coaching
  • Body Composition Analysis
Book your consultation